Literature DB >> 7888108

Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease.

L Soussan1, K Tchernakov, O Bachar-Lavi, T Yuvan, E Wertman, D M Michaelson.   

Abstract

Sera of normal controls and of patients with neurological diseases contain antineurofilament antibodies. Recent studies suggest that biochemically and immunologically distinct subclasses of neurofilaments occur in different types of neurons. Alzheimer's disease (AD), the major cause of dementia, is associated with a marked degeneration of brain cholinergic neurons. In the present work we characterized the repertoire and age dependence of antineurofilament antibodies in normal sera and examined whether the degeneration of cholinergic neurons in AD is associated with serum antibodies directed specifically against the neurofilaments of mammalian cholinergic neurons. This was performed by immunoblot assays utilizing neurofilaments from the purely cholinergic bovine ventral root neurons and from the chemically heterogeneous bovine dorsal root neurons. Antibodies to the heavy neurofilament protein NF-H were detected in normal control sera. Their levels were significantly higher in older (aged 70-79) than in younger (aged 40-59) subjects. These antibodies bound similarly to bovine ventral root and dorsal root NF-H and their NF-H specificity was unchanged during aging. In contrast, the levels of IgG in AD sera that are directed against ventral root cholinergic NF-H were higher than those directed against the chemically heterogeneous dorsal root NF-H. Immunoblot experiments utilizing dephosphorylated ventral root and dorsal root NF-H and chymotryptic fragments of these molecules revealed that AD sera contain a repertoire of antimamalian NF-H IgG. A subpopulation of these antibodies binds to phosphorylated epitopes that are specifically enriched in ventral root cholinergic NF-H and that are located on the carboxy terminal domain of this molecule.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888108     DOI: 10.1007/BF02816107

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  43 in total

1.  Antibodies to neurofilament protein in retinitis pigmentosa.

Authors:  G M Galbraith; D Emerson; H H Fudenberg; C J Gibbs; D C Gajdusek
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

2.  Significance of an aging-linked neuron binding gamma globulin fraction of human sera.

Authors:  C R Ingram; K J Phegan; H T Blumenthal
Journal:  J Gerontol       Date:  1974-01

3.  The structure, biochemical properties, and immunogenicity of neurofilament peripheral regions are determined by phosphorylation state.

Authors:  M J Carden; W W Schlaepfer; V M Lee
Journal:  J Biol Chem       Date:  1985-08-15       Impact factor: 5.157

Review 4.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

5.  Computerized data base for evaluation and follow-up of demented outpatients.

Authors:  A Zemcov; L L Barclay; D Brush; J P Blass
Journal:  J Am Geriatr Soc       Date:  1984-11       Impact factor: 5.562

6.  Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats.

Authors:  V M Lee; M J Carden; W W Schlaepfer; J Q Trojanowski
Journal:  J Neurosci       Date:  1987-11       Impact factor: 6.167

7.  The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases.

Authors:  B H Toh; C J Gibbs; D C Gajdusek; J Goudsmit; D Dahl
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.

Authors:  B Lichtenberg-Kraag; E M Mandelkow; J Biernat; B Steiner; C Schröter; N Gustke; H E Meyer; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

9.  Neurofilament antibodies in systemic lupus erythematosus.

Authors:  P Kurki; T Helve; D Dahl; I Virtanen
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

10.  Antibodies to cholinergic neurons in Alzheimer's disease.

Authors:  J Chapman; O Bachar; A D Korczyn; E Wertman; D M Michaelson
Journal:  J Neurochem       Date:  1988-08       Impact factor: 5.372

View more
  6 in total

1.  Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid.

Authors:  D A Loeffler; P L Juneau; H U Nguyen; D Najman; N Pomara; P A LeWitt
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

2.  Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats.

Authors:  R M Posmantur; X Zhao; A Kampfl; G L Clifton; R L Hayes
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

Review 3.  Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders.

Authors:  Zahra Alirezaei; Mohammad Hossein Pourhanifeh; Sarina Borran; Majid Nejati; Hamed Mirzaei; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.590

Review 4.  Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke.

Authors:  Aldo Bonaventura; Luca Liberale; Alessandra Vecchié; Matteo Casula; Federico Carbone; Franco Dallegri; Fabrizio Montecucco
Journal:  Int J Mol Sci       Date:  2016-11-25       Impact factor: 5.923

Review 5.  Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases.

Authors:  Gabriela Kocurova; Jan Ricny; Saak V Ovsepian
Journal:  Theranostics       Date:  2022-03-28       Impact factor: 11.600

Review 6.  Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder.

Authors:  Rut Mazón-Cabrera; Patrick Vandormael; Veerle Somers
Journal:  Front Immunol       Date:  2019-07-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.